The Effectiveness of Intravitreal Avastin Injection for CRVO

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Ziv Hospital.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Ziv Hospital Identifier:
First received: August 29, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion

Central Retinal Vein Occlusion

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Effectiveness of Intravitreal Avastin Injection for CRVO

Further study details as provided by Ziv Hospital:

Estimated Enrollment: 68
Study Start Date: January 2006

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients who suffer from CRVO and were injected by bevazicumab intravitrealy

Inclusion Criteria:

  • patients above 18 years old
  • suffer from CRVO
  • maximal visual acuity 6/15

Exclusion Criteria:

  • VA of LP
  • retinal disease other than CRVO
  • incomplete medical record
  • follow up less than 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01678248

Contact: Joseph pikkel, M.D 972508434206
Contact: Otzem Chassid, M.D 972506266059

Ziv Medical Center Recruiting
Safed, Israel, 13100
Contact: Otzem Chassid, M.D   
Principal Investigator: Joseph Pikkel, M.D         
Sponsors and Collaborators
Ziv Hospital
  More Information

No publications provided

Responsible Party: Ziv Hospital Identifier: NCT01678248     History of Changes
Other Study ID Numbers: 0048-12-ZIV 
Study First Received: August 29, 2012
Last Updated: August 29, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Retinal Vein Occlusion
Cardiovascular Diseases
Embolism and Thrombosis
Eye Diseases
Retinal Diseases
Vascular Diseases
Venous Thrombosis processed this record on February 04, 2016